Search Results

• • 11 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• MRD Assessment in Multiple Myeloma: Progress and Challenges.

  Authors:Luca Bertamini, Mattia D'Agostino, and Francesca GayFrom:Current Hematologic Malignancy Reports (Vol. 16, Issue 2)

  Apr. 2021294 words Report, Brief articl...

   Abstract Only

• The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens

  Authors:Giulia Benevolo, Alessandra Larocca, Massimo Gentile, Patrizia Pregno, Francesca Gay, Barbara Botto, et al.From:Cancer (Vol. 117, Issue 9) Peer-Reviewed

  May 1, 2011 Clinical report

   Citation Only

• Efficacy of safety and bortezomib in patients with plasma cell leukemia

  Authors:Pellegrino Musto, Fausto Rossini, Francesca Gay, Vincenzo Pitini, Tommasina Guglielmelli, Giovanni D'Arean, et al.From:Cancer (Vol. 109, Issue 11) Peer-Reviewed

  June 1, 2007 Article

   Citation Only

• Time to first disease progression, but not (beta)2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy

  Authors:Antonio Palumbo, Sara Bringhen, Patrizia Falco, Federica Cavallo, Maria Teresa Ambrosini, Ilaria Avonto, et al.From:Cancer (Vol. 110, Issue 4) Peer-Reviewed

  Aug. 15, 2007 Clinical report

   Citation Only

• Management of disease- and treatment-related complications in patients with multiple myeloma

  Authors:Francesca Gay and Antonio PalumboFrom:Medical Oncology (Vol. 27, Issue 1) Peer-Reviewed

  June 2010282 words Report

   Abstract Only

• Melphalan and its role in the management of patients with multiple myeloma

  Authors:Patrizia Falco, Sara Bringhen, Ilaria Avonto, Francesca Gay, Fortunato Morabito, Mario Boccadoro, et al.From:Expert Review of Anticancer Therapy (Vol. 7, Issue 7) Peer-Reviewed

  July 200710,455 words Drug overview 1390LAuthor(s): Patrizia Falco 1 , Sara Bringhen 2 , Ilaria Avonto 3 , Francesca Gay 4 , Fortunato Morabito 5 , Mario Boccadoro 6 , Antonio Palumbo [[dagger]] 7 Keywords : combination therapy; melphalan; multiple...

• Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party study

  Authors:Pellegrino Musto, Vittorio Simeon, Alberto Grossi, Francesca Gay, Sara Bringhen, Alessandra Larocca, et al.From:Stem Cell Research & Therapy (Vol. 6, Issue 1) Peer-Reviewed

  Apr. 17, 20154,086 words Article 1600LIntroduction A still not well defined proportion of patients with multiple myeloma (MM) and eligible for autologous stem cell transplantation (AuSCT) fails to mobilize CD34+ peripheral blood stem cells (PBSC) at all...

• Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

  Authors:Meletios A Dimopoulos, Francesca Gay, Fredrik Schjesvold, Meral Beksac, Roman Hajek, Katja Christina Weisel, et al.From:The Lancet (Vol. 393, Issue 10168) Peer-Reviewed

  Jan. 19, 20191,264 words Article

   Abstract Only

• Nuances in the Management of Older People With Multiple Myeloma

  Authors:Charlotte Pawlyn, Francesca Gay, Alessandra Larocca, Vivek Roy, and Sikander AilawadhiFrom:Current Hematologic Malignancy Reports (Vol. 11, Issue 3)

  June 2016321 words Report

   Abstract Only

• The role of pre-transplant induction regimens and autologous stem cell transplantation in the era of novel targeted agents

  Authors:Francesca Gay, Federica Cavallo, and Antonio PalumboFrom:Drugs (Vol. 75, Issue 4) Peer-Reviewed

  Mar. 1, 2015 Report

   Citation Only

• Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma

  Authors:Shaji K. Kumar, Martha Q. Lacy, Angela Dispenzieri, Francis K. Buadi, Suzanne R. Hayman, David Dingli, et al.From:Cancer (Vol. 118, Issue 6) Peer-Reviewed

  Mar. 15, 2012 Report

   Citation Only